Ariana Pharma
BiotechnologyView the employees at
Ariana Pharma-
Marion Soto VP Business Development at Ariana Pharma
-
Bordeaux, Nouvelle-Aquitaine, France
-
Rising Star
Gabriel Clave Data scientist at Ariana Pharmaceuticals | MINES Paris PSL-
Vitry-sur-Seine, Île-de-France, France
-
Rising Star
Frédéric Parmentier Director, Data Science chez Ariana Pharma-
Greater Paris Metropolitan Region
-
Rising Star
Sebastien Vaucouleur Principal Software Architect-
Top 10%
Anna Shteto Data Scientist / Data Engineer chez Ariana Pharma-
Paris, Île-de-France, France
-
Rising Star
Overview
Ariana Pharma is a leading Artificial Intelligence (AI) drug development company. Using its KEM® Artificial Intelligence (xAI) technology, Ariana helps its partners introduce personalized medicine clinical trial design into their protocols and optimize clinical endpoints, identify biomarkers of therapeutic response and potential synergistic therapies. Ariana routinely collects and combines clinical data with omic data, immunological readouts (such as Fluorescence-Activated Cell Sorting (FACS)), microbiota, Patient Reported Outcomes (PRO) as well as Real World Evidence (RWE) data. Combining advanced data analytics, drug development, and regulatory expertise, Ariana helps translate findings into innovative clinical development plans and regulatory approvals. With a growing number of successful therapeutic development programs, KEM® is an FDA-assessed technology that systematically explores combinations of biomarkers, producing more effective biomarker signatures for precision medicine. Ariana has developed Onco KEM®, the most advanced, clinically tested, oncology therapeutic decision support system. Founded in 2003 as a spin-off of the Institut Pasteur, Paris, France, the company operates a subsidiary in the United States since 2012.
-